ľ Lundbeck Inc. has voluntarily recalled two lots of NeoProfen« (ibuprofen lysine) Injection that failed to meet a visible particulate quality requirement. These two lots are the only lots currently available to prescribers and therefore the recall will result in a temporary drug shortage.

Read More...